Drug details

Bonsity (teriparatide injection, for subcutaneous use)

type of Parathyroid Hormone Analogs

Bonsity (teriparatide injection) is a parathyroid hormone analog (PTH 1- 34) indicated for treatment of postmenopausal women with osteoporosis at high risk for fracture; to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture; and for treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture.

The drug is often used to treat Osteoporosis .

This drug may have the following side effects:

• nausea,
• diarrhea,
• dizziness,
• sore throat
• constipation,
• joint pain,
• headache,
• runny nose,
• indigestion,
• cough, and
• body pain,

The following drugs are related to Bonsity, either as a replacement or used together:

• Actonel (risedronate sodium)
• Fosamax (alendronate sodium)
• Fosamax Plus D (alendronate sodium and cholecalciferol)
• Boniva (ibandronate sodium)
• Boniva Injection (ibandronate sodium injection)
• Forteo (teriparatide (rdna origin) injection)
• Reclast (zoledronic acid injection)